[HTML][HTML] Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
AL Ho, RK Grewal, R Leboeuf… - … England Journal of …, 2013 - Mass Medical Soc
Background Metastatic thyroid cancers that are refractory to radioiodine (iodine-131) are
associated with a poor prognosis. In mouse models of thyroid cancer, selective mitogen …
associated with a poor prognosis. In mouse models of thyroid cancer, selective mitogen …
[引用][C] Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
H Alan L, RK Grewal, R Leboeuf, EJ Sherman… - NEW ENGLAND …, 2013 - iris.unito.it
[引用][C] Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
AL Ho, RK Grewal, R Leboeuf, EJ Sherman… - New England Journal …, 2013 - cir.nii.ac.jp
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.
AL Ho, RK Grewal, R Leboeuf, EJ Sherman… - The New England …, 2013 - europepmc.org
Background Metastatic thyroid cancers that are refractory to radioiodine (iodine-131) are
associated with a poor prognosis. In mouse models of thyroid cancer, selective mitogen …
associated with a poor prognosis. In mouse models of thyroid cancer, selective mitogen …
[引用][C] Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
AL Ho, RK Grewal, R Leboeuf, EJ Sherman, DG Pfister… - L'Endocrinologo, 2013 - Springer
Aumento della captazione del radioiodio indotto da selumetinib in pazienti con cancro della
tiroide Page 1 95 aprile Vol. 14, n 2 Aumento della captazione del radioiodio indotto da …
tiroide Page 1 95 aprile Vol. 14, n 2 Aumento della captazione del radioiodio indotto da …
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
AL Ho, RK Grewal, R Leboeuf, EJ Sherman… - New England Journal …, 2013 - hero.epa.gov
BACKGROUND: Metastatic thyroid cancers that are refractory to radioiodine (iodine-131)
are associated with a poor prognosis. In mouse models of thyroid cancer, selective mitogen …
are associated with a poor prognosis. In mouse models of thyroid cancer, selective mitogen …
[HTML][HTML] Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
AL Ho, RK Grewal, R Leboeuf… - The New England …, 2013 - ncbi.nlm.nih.gov
Background Metastatic thyroid cancers that are refractory to radioiodine (iodine-131) are
associated with a poor prognosis. In mouse models of thyroid cancer, selective mitogen …
associated with a poor prognosis. In mouse models of thyroid cancer, selective mitogen …
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
J Fagin - Endocrine Abstracts, 2014 - endocrine-abstracts.org
Oncogenic activation of MAPK in thyroid cells leads to loss of expression of genes required
for thyroid hormone biosynthesis, including the sodium iodide transporter (NIS) and thyroid …
for thyroid hormone biosynthesis, including the sodium iodide transporter (NIS) and thyroid …
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
AL Ho, RK Grewal, R Leboeuf… - The New England …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Metastatic thyroid cancers that are refractory to radioiodine (iodine-131) are
associated with a poor prognosis. In mouse models of thyroid cancer, selective mitogen …
associated with a poor prognosis. In mouse models of thyroid cancer, selective mitogen …
[PDF][PDF] inAdvancedThyroidCancer
S me tin ib-EnhancedRadioiodineUptake - N Engl J Med, 2013 - sys.91sqs.net
Methods Weconductedastudytodeterminewhetherthe… (MEK) 1 andMEK2 inhibitorselu me
tin ib (AZD6244, ARRY-142886) couldreverserefractorinesstoradioiodineinp …
tin ib (AZD6244, ARRY-142886) couldreverserefractorinesstoradioiodineinp …